FDA-Approved Autograft Sparing Device for National Preparedness
Awarded on April 9, 2026. Full description on SAM.gov.
Overview
- Posted
- April 13, 2026
- Notice type
- Award Notice
- NAICS
- 339113: Surgical Appliance and Supplies Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Place of performance
- Washington, District of Columbia
- Last updated
- Nov 1, 2026
- First published
- Last updated on SAM.gov
- Award date
- Apr 9, 2026
- Award amount (SAM.gov award notice)
- $25.5M
Identifiers
- Solicitation number
- 75A50125R00003
- Notice ID
- d87d16d0a1e34cf8ae60c9a9bbff5599
- Award number (PIID)
- 75A50126C00003
Description
FDA-Approved Autograft Sparing Device for National Preparedness. Capabilities for building national preparedness against large burn mass casualty incidences (BMCI) as they could quickly overwhelm the US healthcare infrastructure. Treatment and care for burn injuries in adults and childern is labor intensive and influenced by the unique properties of each case with complicating factors including patient age and health as well as burn area and depth. The challenges of providing definitive burn care are heightened when delivering treatment after a mass casualty event in a resource strained environment. Autografting is the current standard of care for long term treatment and recovery of deep partial and full thickness burn injuries. This involves removing healthy skin from an uninjured area of the patient’s body and affixing it on top of the burn wound. The autografting procedure is labor-intensive, requires training, is time consuming and invokes additional risk to the patient due to the operative procedures at multiple sites. Discussions with the professional burn community and market research data indicates that products that reduce the amounts of autograft needed to provide wound closure (autograft-sparing) can provide an advantage for rapid and effective care of severe burn injuries. Such products also have the potential to reduce the morbidity of the donor sites. Such products should be compatible with current procedures to allow easy integration so they could be also used during a mass casualty scenario involving significantly high numbers of burn patients. Additionally, such products that have additional indications for full thickness skin defects due to traumatic injury would be advantageous to address other injuries which result in a mass casualty incident (MCI).
Award Overview
Award Number
75A50126C00003
Award Amount (SAM.gov award notice)
$25.5M
Award Date
Apr 9, 2026
Awardee
Awardee UEI
JY1HRCEKX2L4
Awardee CAGE Code
5Y3N7
Awardee Address
Valencia, CA 91355, UNITED STATES
Original Solicitation
Notice ID: d87d16d0a1e34cf8ae60c9a9bbff5599
Posted Date: Apr 13, 2026
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Documents
Files (3)
- Download
Amendment 1 Questions and Responses for Solicitiation 75A50125R00003.pdf
93 KBAdded in Solicitation version 3Posted - Download
ATTACHMENT 9 BREAKDOWN OF PROPOSED COSTS WITH EXCEL SPREADSHEET.xlsx
110 KBAdded in Solicitation version 1Posted - Download
Request for Proposal 75A50125R00003 Autograft Sparing Devices.pdf
831 KBAdded in Solicitation version 1Posted
Lifecycle
- 2Version 2SolicitationArchived
Request for Proposal _ Autograft Sparing Device
- 5Version 5Award NoticeArchivedCurrent
Type changed from Solicitation to Award Notice
FDA-Approved Autograft Sparing Device for National Preparedness
Other notices for this solicitation
- SolicitationRelated noticeJun 4, 2025
Request for Proposal _ Autograft Sparing Device
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50125R00003
Archive Date
Apr 24, 2026
Office Address
WASHINGTON, DC, 20515